BACKGROUND AND PURPOSE: The aim of this study was to analyze epileptic seizures and their impact on outcome in patients with stroke treated with endovascular therapy. METHODS: From December 1992 to December 2010 we managed 805 patients with stroke with endovascular therapy. Epileptic seizures, bleeding complications, and 3-month outcomes were recorded prospectively. Outcomes of patients with early seizures (within 24 hours of stroke onset) and patients with late seizures (>24 hours after stroke) were compared with outcomes of seizure-free patients using uni- and multivariable statistics. RESULTS: Forty-four of 805 patients (5.5%) had seizures between stroke onset and 3-month follow-up, 26 patients early and 18 late. Outcome of patients with late seizures and seizure-free patients was similar (P=0.144 and 0.807). Patients with early seizures had higher baseline National Institutes of Health Stroke Scale (P=0.023) and were younger (P=0.021) than seizure-free patients. Their mortality rate was 50% compared with 22.3% of the seizure free-patients (P=0.003), and less patients reached a favorable outcome (modified Rankin Scale 0-2): 15.4% and 46.8%, respectively (P=0.001). Early seizures independently predicted an unfavorable outcome (P=0.014; OR, 4.749; 95% CI, 0.376-3.914) and increased mortality (P=0.001; OR, 5.861; 95% CI, 0.770-2.947) in multiregression analysis. Patients with early seizures had a 1.6-fold higher risk for unfavorable outcome and a 2.2-fold higher risk for death compared with seizure-free patients. CONCLUSIONS: Seizures within 24 hours of stroke onset were associated with worse outcome in patients with stroke undergoing endovascular therapy. Our findings confirm a need for trials for prophylactic anticonvulsive treatment in patients receiving endovascular therapy for acute stroke.
BACKGROUND AND PURPOSE: The aim of this study was to analyze epileptic seizures and their impact on outcome in patients with stroke treated with endovascular therapy. METHODS: From December 1992 to December 2010 we managed 805 patients with stroke with endovascular therapy. Epileptic seizures, bleeding complications, and 3-month outcomes were recorded prospectively. Outcomes of patients with early seizures (within 24 hours of stroke onset) and patients with late seizures (>24 hours after stroke) were compared with outcomes of seizure-freepatients using uni- and multivariable statistics. RESULTS: Forty-four of 805 patients (5.5%) had seizures between stroke onset and 3-month follow-up, 26 patients early and 18 late. Outcome of patients with late seizures and seizure-freepatients was similar (P=0.144 and 0.807). Patients with early seizures had higher baseline National Institutes of Health Stroke Scale (P=0.023) and were younger (P=0.021) than seizure-freepatients. Their mortality rate was 50% compared with 22.3% of the seizure free-patients (P=0.003), and less patients reached a favorable outcome (modified Rankin Scale 0-2): 15.4% and 46.8%, respectively (P=0.001). Early seizures independently predicted an unfavorable outcome (P=0.014; OR, 4.749; 95% CI, 0.376-3.914) and increased mortality (P=0.001; OR, 5.861; 95% CI, 0.770-2.947) in multiregression analysis. Patients with early seizures had a 1.6-fold higher risk for unfavorable outcome and a 2.2-fold higher risk for death compared with seizure-freepatients. CONCLUSIONS:Seizures within 24 hours of stroke onset were associated with worse outcome in patients with stroke undergoing endovascular therapy. Our findings confirm a need for trials for prophylactic anticonvulsive treatment in patients receiving endovascular therapy for acute stroke.
Authors: Richard McKinley; Levin Häni; Jan Gralla; M El-Koussy; S Bauer; M Arnold; U Fischer; S Jung; Kaspar Mattmann; Mauricio Reyes; Roland Wiest Journal: J Cereb Blood Flow Metab Date: 2016-01-01 Impact factor: 6.200
Authors: Aida Rodriguez-Sainz; Ana Pinedo-Brochado; Jose L Sánchez-Menoyo; Javier Ruiz-Ojeda; Ines Escalza-Cortina; Juan Carlos Garcia-Monco Journal: Curr Treat Options Cardiovasc Med Date: 2013-06
Authors: Lindsey R Kuohn; Alison L Herman; Alexandria L Soto; Stacy C Brown; Emily J Gilmore; Lawrence J Hirsch; Charles C Matouk; Kevin N Sheth; Jennifer A Kim Journal: J Stroke Cerebrovasc Dis Date: 2021-10-21 Impact factor: 2.136
Authors: Rudolf Luedi; Kety Hsieh; Agnieszka Slezak; Marwan El-Koussy; Urs Fischer; Mirjam R Heldner; Julia Meisterernst; Marie-Luise Mono; Christoph Zubler; Pasquale Mordasini; Christoph Ozdoba; Heinrich P Mattle; Gerhard Schroth; Jan Gralla; Marcel Arnold; Simon Jung Journal: J Neurol Date: 2014-06-11 Impact factor: 4.849
Authors: Julia Meisterernst; Pascal P Klinger-Gratz; Lars Leidolt; Matthias F Lang; Gerhard Schroth; Pasquale Mordasini; Mirjam R Heldner; Marie-Luise Mono; Rebekka Kurmann; Monika Buehlmann; Urs Fischer; Marcel Arnold; Jan Gralla; Heinrich P Mattle; Marwan El-Koussy; Simon Jung Journal: PLoS One Date: 2017-09-28 Impact factor: 3.240
Authors: Simon Habegger; Roland Wiest; Bruno J Weder; Pasquale Mordasini; Jan Gralla; Levin Häni; Simon Jung; Mauricio Reyes; Richard McKinley Journal: Front Neurol Date: 2018-09-11 Impact factor: 4.003
Authors: Sebastian Bellwald; Rupashani Balasubramaniam; Michael Nagler; Meret S Burri; Samuel D A Fischer; Arsany Hakim; Tomas Dobrocky; Yannan Yu; Fabien Scalzo; Mirjam R Heldner; Roland Wiest; Marie-Luise Mono; Hakan Sarikya; Marwan El-Koussy; Pasquale Mordasini; Urs Fischer; Gerhard Schroth; Jan Gralla; Heinrich P Mattle; Marcel Arnold; David Liebeskind; Simon Jung Journal: PLoS One Date: 2018-09-26 Impact factor: 3.240